J Trent Magruder1, Joshua C Grimm2, Arman Kilic2, Todd Crawford2, John V Conte2, Duke E Cameron2, Ashish S Shah3. 1. Division of Cardiac Surgery, Johns Hopkins School of Medicine, Baltimore, MD, USA. jmagrud3@jhmi.edu. 2. Division of Cardiac Surgery, Johns Hopkins School of Medicine, Baltimore, MD, USA. 3. Department of Cardiac Surgery, Vanderbilt University School of Medicine, 1215 21st Avenue South, Suite 5025, Nashville, TN, 37232, USA. ashish.s.shah@vanderbilt.edu.
Abstract
OBJECTIVES: We sought to determine whether an AVR performed though a partial upper hemisternotomy ("mini-AVR") resulted in a greater incidence of patient-prosthesis mismatch (PPM) than those through a full median sternotomy ("AVR"). METHODS: Patients undergoing isolated aortic valve replacement from 2008 to 2013 were identified. Moderate PPM was defined as an in vivo effective orifice area ≤0.85 cm(2)/m(2) body surface area; severe PPM was defined as ≤0.65 cm(2)/m(2). A propensity score-matched analysis was utilized to compare the incidence of PPM between these groups. RESULTS: Of the 630 patients undergoing aortic valve surgery, 90 (14.3%) received mini-AVRs and 540 (85.7%) received regular AVRs. After propensity matching, we established two cohorts of 85 patients receiving each procedure. Both cohorts were similar with regard to all preoperative covariates including mean age (65.5 vs. 65.1, p = 0.85), diabetes (17.7 vs. 22.4%), mean BMI (28.3 vs. 28.6, p = 0.73), mean EF (56.9 vs. 55.6, p = 0.43), proportion of patients with aortic stenosis (70.6 vs. 71.8%, p = 1.00), preoperative valve area (0.88 vs. 0.93 cm(2), p = 0.67), and proportion who received a bioprosthesis (85.9 vs. 83.5%, p = 0.59). Postoperatively, 27.4% of mini-AVRs and 26.8% of AVRs had moderate PPM (p = 0.93); 2.4 and 1.2% had severe PPM (p = 0.66). Kaplan-Meier analysis also failed to reveal a difference in 1-year survival between mini and regular AVRs (93.7 vs. 90.5%, p = 0.49). CONCLUSIONS: After propensity matching, mini-AVRs are not associated with a greater incidence of PPM than regular AVRs. Severe PPM was rare across both procedure types in this surgical series.
OBJECTIVES: We sought to determine whether an AVR performed though a partial upper hemisternotomy ("mini-AVR") resulted in a greater incidence of patient-prosthesis mismatch (PPM) than those through a full median sternotomy ("AVR"). METHODS:Patients undergoing isolated aortic valve replacement from 2008 to 2013 were identified. Moderate PPM was defined as an in vivo effective orifice area ≤0.85 cm(2)/m(2) body surface area; severe PPM was defined as ≤0.65 cm(2)/m(2). A propensity score-matched analysis was utilized to compare the incidence of PPM between these groups. RESULTS: Of the 630 patients undergoing aortic valve surgery, 90 (14.3%) received mini-AVRs and 540 (85.7%) received regular AVRs. After propensity matching, we established two cohorts of 85 patients receiving each procedure. Both cohorts were similar with regard to all preoperative covariates including mean age (65.5 vs. 65.1, p = 0.85), diabetes (17.7 vs. 22.4%), mean BMI (28.3 vs. 28.6, p = 0.73), mean EF (56.9 vs. 55.6, p = 0.43), proportion of patients with aortic stenosis (70.6 vs. 71.8%, p = 1.00), preoperative valve area (0.88 vs. 0.93 cm(2), p = 0.67), and proportion who received a bioprosthesis (85.9 vs. 83.5%, p = 0.59). Postoperatively, 27.4% of mini-AVRs and 26.8% of AVRs had moderate PPM (p = 0.93); 2.4 and 1.2% had severe PPM (p = 0.66). Kaplan-Meier analysis also failed to reveal a difference in 1-year survival between mini and regular AVRs (93.7 vs. 90.5%, p = 0.49). CONCLUSIONS: After propensity matching, mini-AVRs are not associated with a greater incidence of PPM than regular AVRs. Severe PPM was rare across both procedure types in this surgical series.
Authors: Nicolas Doll; Michael A Borger; Joerg Hain; Jan Bucerius; Thomas Walther; Jan F Gummert; Friedrich W Mohr Journal: Ann Thorac Surg Date: 2002-10 Impact factor: 4.330
Authors: Alaaddin Yilmaz; Jelena Sjatskig; Wim J van Boven; Frans G Waanders; Johannes C Kelder; Uday Sonker; Geoffrey T L Kloppenburg Journal: Scand Cardiovasc J Date: 2011-08-19 Impact factor: 1.589
Authors: H E Mächler; P Bergmann; M Anelli-Monti; D Dacar; P Rehak; I Knez; L Salaymeh; E Mahla; B Rigler Journal: Ann Thorac Surg Date: 1999-04 Impact factor: 4.330
Authors: Marc Ruel; Hussam Al-Faleh; Alexander Kulik; Kwan L Chan; Thierry G Mesana; Ian G Burwash Journal: J Thorac Cardiovasc Surg Date: 2006-05 Impact factor: 5.209
Authors: Dania Mohty; Jean G Dumesnil; Najmeddine Echahidi; Patrick Mathieu; François Dagenais; Pierre Voisine; Philippe Pibarot Journal: J Am Coll Cardiol Date: 2009-01-06 Impact factor: 24.094
Authors: Melanie Freeman; John G Webb; Alexander B Willson; Miriam Wheeler; Philipp Blanke; Robert R Moss; Christopher R Thompson; Brad Munt; Bjarne L Norgaard; Tae-Hyun Yang; James K Min; Steen Poulsen; Nicolaj C Hansson; Ronald K Binder; Stefan Toggweiler; Cameron Hague; David A Wood; Philippe Pibarot; Jonathon Leipsic Journal: J Cardiovasc Comput Tomogr Date: 2013-08-23